Lam WWC - Search Results

1

Radiolabeled Liposomes for Nuclear Imaging Probes.

Low HY, Yang CT, Xia B, He T, Lam WWC, Ng DCE. Low HY, et al. Among authors: lam wwc. Molecules. 2023 Apr 28;28(9):3798. doi: 10.3390/molecules28093798. Molecules. 2023. PMID: 37175207 Free PMC article. Review.

2

Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience.

Lam WW, Ng DC, Wong WY, Ong SC, Yu SW, See SJ. Lam WW, et al. Clin Neurol Neurosurg. 2011 Feb;113(2):156-61. doi: 10.1016/j.clineuro.2010.09.012. Epub 2010 Oct 30. Clin Neurol Neurosurg. 2011. PMID: 21036467

3

SPECT/CT in musculoskeletal infections.

Thang SP, Tong AK, Lam WW, Ng DC. Thang SP, et al. Semin Musculoskelet Radiol. 2014 Apr;18(2):194-202. doi: 10.1055/s-0034-1371020. Epub 2014 Apr 8. Semin Musculoskelet Radiol. 2014. PMID: 24715450 Review.

4

Current Status and Growth of Nuclear Theranostics in Singapore.

Huang HL, Tong AKT, Thang SP, Yan SX, Lam WWC, Loke KSH, Tang CYL, Cheng LTJ, Ooi GSK, Low HC, Magsombol BM, Tham WY, Goh CXY, Tan CJ, Khor YM, Zaheer S, Bharadwaj P, Xie W, Ng DCE. Huang HL, et al. Among authors: lam wwc. Nucl Med Mol Imaging. 2019 Apr;53(2):96-101. doi: 10.1007/s13139-019-00580-3. Epub 2019 Jan 25. Nucl Med Mol Imaging. 2019. PMID: 31057680 Free PMC article.

5

Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020?

Lam WW, Loke KS, Wong WY, Ng DC. Lam WW, et al. Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1645-1648. doi: 10.1007/s00259-020-04790-2. Epub 2020 Mar 30. Eur J Nucl Med Mol Imaging. 2020. PMID: 32232520 Free PMC article.

6

Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer-a prospective pilot study in an Asian population.

Thang SP, Lam WWC, Tong AKT, Allen JC Jr, Ler ASL, Tay YS, Somanesan S, Kanesvaran R, Wong ASC, Ng DCE. Thang SP, et al. Among authors: lam wwc. Nucl Med Commun. 2020 Jul;41(7):618-628. doi: 10.1097/MNM.0000000000001179. Nucl Med Commun. 2020. PMID: 32282629 Clinical Trial.

7

Outcomes and prognostic predictors of Lu-177 PSMA radioligand therapy in metastatic castration-resistant prostate cancer (Asian Population Study).

Chua WM, Lam WW, Tong AK, Sultana R, Kua SMY, Kanesvaran R, Wong ASC, Tay KJ, Cheng TJL, Ng DCE, Thang SP. Chua WM, et al. Asia Pac J Clin Oncol. 2023 Mar 31. doi: 10.1111/ajco.13944. Online ahead of print. Asia Pac J Clin Oncol. 2023. PMID: 36999335

8

Safety and efficacy of peptide receptor radionuclide therapy in patients with advanced pheochromocytoma and paraganglioma: A single-institution experience and review of the literature.

Tang CYL, Chua WM, Huang HL, Lam WW, Loh LM, Tai D, Ong SYK, Yan SX, Loke KSH, Ng DC, Tham WY. Tang CYL, et al. J Neuroendocrinol. 2023 Dec;35(12):e13349. doi: 10.1111/jne.13349. Epub 2023 Nov 8. J Neuroendocrinol. 2023. PMID: 37937484

9

Myoepithelial hyperplasia: A rare mimic of breast cancer on ¹⁸ F-FDG PET/CT.

Tang CYL, Lam WW, Tan PH, Xie W, Peh WM, Tan VK, Leong LCH. Tang CYL, et al. Breast J. 2020 Apr;26(4):775-777. doi: 10.1111/tbj.13643. Epub 2019 Sep 28. Breast J. 2020. PMID: 31562674 No abstract available.

10

¹⁸F-FDG PET/CT Manifestations of IgG4-related Disease.

Tang CYL, Chua WM, Cheng LTJ, Fong W, Zaheer S, Lam WW. Tang CYL, et al. Br J Radiol. 2021 Aug 1;94(1124):20210105. doi: 10.1259/bjr.20210105. Epub 2021 May 28. Br J Radiol. 2021. PMID: 34048289 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page